BC Road: Muslim youth stabbed during RSS activist’s funeral procession

Belgaum, Mar 30: As many as 2442 labourers hailing from Karnataka have been brought back in 62 buses by the State government from Maharashtra on Sunday, in the backdrop of nation-wide lockdown following COVID-19 outbreak.

Maharashtra Chief Minister Uddhav Thackeray on Saturday urged migrant labourers not to leave the State owing to the nationwide lockdown and assured that the Maharashtra government will look after their interests.

Hundreds of migrants, a majority of whom are daily wage workers started rushing to their native places from different states amid uncertainty over their livelihood following the announcement of a 21-day nationwide lockdown by Prime Minister Narendra Modi last week in order to contain the spread of novel coronavirus.

Udupi, Apr 9: Deputy Commissioner G. Jagadeesha said that criminal cases would be booked against owners of houses and sheds who were collecting rent from those, including workers, staying in rented houses.

In a statement issued here on Wednesday, Mr Jagadeesha said that to prevent the spread of COVID-19, restrictions had been imposed throughout the district under Section 144 (3) of the Criminal Procedure Code.

The administration had through an earlier order made it clear that house owners and shed owners should not collect rent from their tenants and workers for March and April.

But the administration had received complaints that some house owners and shed owners were collecting rent despite the order.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.